- Home
- HBCP vs HQL Comparison
HBCP vs HQL Comparison
Compare HBCP & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBCP
- HQL
- Stock Information
- Founded
- HBCP 1908
- HQL 1992
- Country
- HBCP United States
- HQL United States
- Employees
- HBCP N/A
- HQL N/A
- Industry
- HBCP Banks
- HQL Investment Managers
- Sector
- HBCP Finance
- HQL Finance
- Exchange
- HBCP Nasdaq
- HQL Nasdaq
- Market Cap
- HBCP 431.6M
- HQL 369.6M
- IPO Year
- HBCP 2008
- HQL N/A
- Fundamental
- Price
- HBCP $55.77
- HQL $12.98
- Analyst Decision
- HBCP Buy
- HQL
- Analyst Count
- HBCP 2
- HQL 0
- Target Price
- HBCP $57.50
- HQL N/A
- AVG Volume (30 Days)
- HBCP 73.9K
- HQL 120.9K
- Earning Date
- HBCP 07-21-2025
- HQL 01-01-0001
- Dividend Yield
- HBCP 1.93%
- HQL 11.56%
- EPS Growth
- HBCP 0.90
- HQL N/A
- EPS
- HBCP 4.78
- HQL 0.79
- Revenue
- HBCP $135,421,000.00
- HQL N/A
- Revenue This Year
- HBCP $0.25
- HQL N/A
- Revenue Next Year
- HBCP $5.18
- HQL N/A
- P/E Ratio
- HBCP $11.73
- HQL $17.08
- Revenue Growth
- HBCP 3.44
- HQL N/A
- 52 Week Low
- HBCP $37.35
- HQL $11.34
- 52 Week High
- HBCP $56.94
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- HBCP 69.66
- HQL 58.87
- Support Level
- HBCP $55.01
- HQL $12.99
- Resistance Level
- HBCP $56.80
- HQL $13.45
- Average True Range (ATR)
- HBCP 1.31
- HQL 0.17
- MACD
- HBCP 0.31
- HQL 0.02
- Stochastic Oscillator
- HBCP 94.23
- HQL 64.10
About HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.